The WHO’s decision to keep coca leaf under strict controls highlights weak legal reasoning, disregard for scientific evidence, and ongoing harms to Indigenous rights.
The VNGOC and 125 co-signing organisations have issued an open letter to the UN, calling for urgent reforms to address procedural barriers that effectively exclude civil society.
Türkiye has re-nominated Prof. Sevil Atasoy for re-election to the International Narcotics Control Board, highlighting her extensive experience and commitment to human-centred, evidence-based global drug policies.
UN experts say that Saudi Arabia’s use of the death penalty for drug offences violates international law, highlighting serious due process violations and discriminatory impacts on foreign nationals.
The INCB examines mounting pressures on the global drug control system, from synthetic drugs and access to medicines to increasing fragmentation within the Commission on Narcotic Drugs.
Outgoing IDPC Executive Director, Ann Fordham reflects on the evolution of global drug policy, the growth of civil society advocacy, and the urgent need to defend hard-won progress.
In her final CND as IDPC ED, Ann Fordham reflects on a historic shift: the recognition of harm reduction in UN drug policy debates, amid rising geopolitical tensions, fractured consensus, and a multilateral system under strain.
IDPC welcomes Resolution 60/26 as a landmark affirmation of the Council's authority to address the human rights implications of drug policy, strengthening the UN human rights system and reinforcing calls for health-, rights- and evidence-based drug policies globally.
The WHO has upheld the coca leaf’s severe international scheduling, maintaining restrictions despite evidence of its safety and longstanding Indigenous use.
